Gestational diabetes
High blood sugar first recognized during pregnancy.
Gestational diabetes is a condition where high blood sugar develops during pregnancy in someone who did not previously have diabetes. It is formally defined as any degree of glucose intolerance that is first recognized during pregnancy, which means it may include cases where undiagnosed diabetes existed before conception or developed coincidentally with pregnancy. The condition often produces few noticeable symptoms. It is most common in the third trimester, affecting between 3% and 9% of pregnancies, though rates vary by population due to differing screening methods and diagnostic criteria. Prevalence is lower in those under 20 years old and higher in those over 44. Certain ethnic groups—including Asians, American Indians, Indigenous Australians, and Pacific Islanders—face elevated risk. The underlying causes involve insulin resistance or insufficient insulin production during pregnancy. Risk factors include being overweight, a prior history of gestational diabetes, a family history of type 2 diabetes, and polycystic ovarian syndrome. Diagnosis relies on blood tests, with screening recommended between 24 and 28 weeks for those at normal risk, and earlier for high-risk individuals. The White classification system, named after researcher Priscilla White, distinguishes gestational diabetes (type A) from pregestational diabetes, and further subdivides gestational diabetes into type A1, where diet alone controls glucose, and type A2, requiring medication or insulin. Other diagnostic criteria include the Carpenter-Coustan and National Diabetes Data Group thresholds, as well as the DIPSI guidelines used in India, which use a single two-hour plasma glucose value of 140 mg/dL or higher after a 75-gram glucose load. Untreated gestational diabetes raises risks for the baby, including macrosomia (excessive birth weight), neonatal hypoglycemia, jaundice, and stillbirth. Long-term, children have higher odds of overweight and type 2 diabetes. For the mother, obesity increases the likelihood of pre-eclampsia, cesarean delivery, and macrosomia. Management involves healthy eating, exercise, medication such as metformin, and sometimes insulin injections; most people control blood sugar with diet and exercise alone, and blood sugar testing four times daily is often recommended. Breastfeeding soon after birth is encouraged.
Quick Facts
- Field
- Obstetrics and endocrinology
- Symptoms
- Typically few symptoms
- Complications
- Pre-eclampsia
- stillbirth
- depression
- increased risk of requiring a caesarean section
- Onset
- Most common last three months of pregnancy
- Causes
- Not enough insulin in the setting of insulin resistance
- Risks
- Overweight
- previously having gestational diabetes
- family history of type 2 diabetes
- polycystic ovarian syndrome
- Diagnosis
- Screening blood tests
- Prevention
- Maintaining a healthy weight and exercising before pregnancy
Facts from the source article.
Lore & Background
Gestational diabetes is a condition where high blood sugar develops during pregnancy in someone who did not previously have diabetes, typically producing few noticeable symptoms. It arises from insulin resistance or reduced insulin production. Diagnosis relies on blood tests; for those at normal risk, screening is recommended between 24 and 28 weeks of gestation, while high-risk individuals may be tested at the first prenatal visit. The condition is formally defined as any degree of glucose intolerance first recognized during pregnancy, regardless of whether it resolves after birth. The White classification system distinguishes gestational diabetes (type A) from pregestational diabetes, with type A1 managed by diet alone and type A2 requiring insulin or other medications. Diagnostic criteria vary: the Carpenter and Coustan guidelines use a 100-gram glucose tolerance test with fasting, one-hour, two-hour, and three-hour thresholds of 95, 180, 155, and 140 mg/dL, respectively; the National Diabetes Data Group sets higher cutoffs (105, 190, 165, and 145 mg/dL). The DIPSI guidelines, approved in India, diagnose gestational diabetes with a single two-hour plasma glucose value of 140 mg/dL or higher after a 75-gram glucose load, allowing non-fasting testing in low-resource settings. Risk factors include being overweight, prior gestational diabetes, family history of type 2 diabetes, and polycystic ovarian syndrome. Genetic factors also play a role, with polymorphisms in at least ten genes—most notably TCF7L2 and MTNR1B—linked to increased risk. Gestational diabetes affects 3–9% of pregnancies, peaking in the third trimester, and is more common in Asians, American Indians, Indigenous Australians, and Pacific Islanders. It occurs in 1% of pregnancies under age 20 and 13% over age 44. Obesity raises the rates of pre-eclampsia, cesarean sections, and fetal macrosomia. Poorly treated cases increase risks for the baby, including macrosomia (birth weight over 4,000 g), neonatal hypoglycemia, jaundice, and stillbirth. Long-term, children face higher odds of overweight and type 2 diabetes. In 90% of cases, the condition resolves after delivery, but affected individuals remain at elevated risk for developing type 2 diabetes later.
Reader's Guide
Gestational diabetes is significant because it affects a substantial proportion of pregnancies worldwide and carries both immediate and long-term health implications for mother and child. The condition highlights the interplay between pregnancy hormones and insulin resistance, with placental hormones like cortisol and progesterone contributing to reduced insulin action. The White classification system provides a framework for assessing risk and guiding management, distinguishing between diet-controlled and medication-required cases. The legacy of gestational diabetes research includes improved screening protocols, such as universal screening between 24 and 28 weeks, and preventive measures like maintaining a healthy weight and exercising before pregnancy. Long-term, children of affected pregnancies are at higher risk of obesity and type 2 diabetes, while mothers face increased risk of developing type 2 diabetes themselves. The condition's variability across populations—due to genetic factors, screening strategies, and diagnostic criteria—underscores the need for tailored approaches in different settings. The DIPSI guidelines, for example, offer a simplified test suitable for low-resource environments. Overall, gestational diabetes serves as a critical window for intervention that can reduce perinatal complications and mitigate future metabolic disease.
Frequently Asked Questions
What are Gestational diabetes's role in the story?
Its main effect is raising maternal blood glucose, which in turn increases the risk of complications for both the expecting parent and the developing baby. Notably, it usually presents with few or no outward symptoms, making routine screening the primary way it gets caught.
How widespread is Gestational diabetes in the 'universe'?
It affects roughly 3–9 % of all pregnancies, with the rate climbing sharply by age: about 1 % for those under 20 but jumping to around 13 % for those over 44. Its peak activity window is the third trimester, when hormonal shifts most strongly stress glucose regulation.
More in Common Diseases & Disorders
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced